Head of Endocrinology and Diabetes at Western Health and consultant endocrinologist at The Alfred, Melbourne who specialises in endocrinology & diabetes.

Associate Professor Hamblin is the Program Director of our Endocrinology (Clinical) research program.

Research Focus

The Endocrinology & Diabetes Unit at Western Health provides a broad clinical service covering type 1 and type 2 diabetes, diabetic foot, insulin pumps, continuous glucose monitoring, endocrinology, obstetric endocrinology and metabolic bone. Clinical research areas focus on diabetes, metabolic bone disease and obstetric endocrinology.

Research activities include

• obstetric outcomes in women with type 1 diabetes, type 2 diabetes and gestational diabetes;
• dental health of young adults with diabetes;
• COVID DINGO study: the impact of COVID19 on outcomes in people with diabetes (multi-centre study led by Royal Melbourne Hospital);
• diabetic ketoacidosis associated with SGLT2 inhibitors;
• capillary ketone levels In colonoscopy;
• the role of 4D CT in parathyroid adenoma localisation;
• causes and outcomes of severe inpatient hypernatraemia;
• collaborative research with Prof Gustavo Duque on the effects of parathyroidectomy in frail older persons (Frail-pathy study) and the ORMA study, an evaluation of an IT program to assist GPs diagnose and manage osteoporosis;
• CD-IMPACT study in association with the Department of Nephrology and studies in association with Deakin University: type 1 diabetes attitudes and management in University students;
• usefulness of an app for dietary choices to help people with type 2 diabetes;
• understanding of diabetes medications in the Vietnamese community;
• with Baker Heart Institute, the PREDICT study (a long term observational study of type 2 diabetes) and the NOX1/4 trial in type 1 diabetic nephropathy;
• with the George Institute the FIELD1 study (effect of fenofibrate on retinopathy In type 1 diabetes);  and
• with RMIT University the psychological impact of gestational diabetes.